Establishment Labs Holdings Inc. (ESTA) financials: revenue, earnings and cash flow
Fiscal 2017–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Establishment Labs’s revenue went from $35M in fiscal 2017 to $211M in fiscal 2025, growth of about 25.3% a year.
Net income in fiscal 2025 was -$51M, a net margin of -24.2%; the best year in this period was 2018 with -$21M.
Over the twelve months to September 30, 2026, revenue was $264M and net income -$38M.
Free cash flow was -$57M in fiscal 2025 and positive in 0 of the 9 years shown.
The diluted share count rose 190% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $264M | $211M | $166M | $165M | $162M | $127M | $85M | $90M | $61M | $35M |
| Gross profit | $185M | $146M | $110M | $107M | $107M | $85M | $53M | $55M | $36M | $18M |
| Operating income | -$17M | -$39M | -$50M | -$65M | -$40M | -$25M | -$28M | -$31M | -$24M | -$20M |
| Net income | -$38M | -$51M | -$85M | -$79M | -$75M | -$41M | -$38M | -$38M | -$21M | -$35M |
| EPS (diluted) | $-1.27 | $-1.72 | $-3.00 | $-3.07 | $-3.08 | $-1.72 | $-1.63 | $-1.86 | $-1.22 | $-3.41 |
| R&D | $20M | $20M | $20M | $26M | $20M | $18M | $14M | $15M | $13M | $7M |
| Revenue growth | — | +27.1% | +0.5% | +2.1% | +27.6% | +49.6% | −5.5% | +46.3% | +76.5% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$13M | -$51M | -$59M | -$89M | -$52M | -$28M | -$13M | -$30M | -$34M | -$32M |
| Capital spending | -$8M | -$6M | -$6M | -$8M | -$3M | -$2M | -$2M | -$6M | -$2M | -$901000 |
| Free cash flow | -$22M | -$57M | -$65M | -$96M | -$55M | -$30M | -$15M | -$36M | -$36M | -$33M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | — | — | — | — | — | — | — | $0 | $5M |
| Stock-based pay | $12M | $11M | $14M | $14M | $13M | $10M | $6M | $7M | $7M | — |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $76M | $90M | $40M | $66M | $53M | $85M | $38M | $53M | $11M |
| Debt | — | $252M | $225M | $192M | $179M | $54M | $53M | $48M | $22M | $0 |
| Equity | — | $24M | $53M | $18M | -$8M | $51M | $75M | $40M | $69M | -$5M |
| Total assets | — | $357M | $347M | $269M | $211M | $140M | $156M | $117M | $117M | $57M |
| Shares (diluted) | 30M | 30M | 28M | 26M | 24M | 24M | 23M | 21M | 17M | 10M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 70.2% | 69.3% | 66.0% | 64.8% | 65.9% | 67.4% | 62.0% | 61.3% | 59.0% | 51.0% |
| Operating margin | -6.6% | -18.5% | -30.1% | -39.4% | -24.5% | -19.8% | -33.0% | -34.5% | -39.0% | -57.6% |
| Net margin | -14.6% | -24.2% | -50.9% | -47.5% | -46.5% | -32.5% | -45.0% | -42.6% | -34.5% | -100.6% |
| FCF margin | -8.2% | -27.0% | -38.9% | -58.4% | -34.0% | -23.6% | -17.3% | -40.5% | -58.2% | -94.8% |
| ROIC | — | -12.5% | -17.9% | -30.8% | -18.3% | -18.9% | -17.3% | -27.9% | -20.5% | — |
| ROE | — | -216.9% | -159.3% | -426.8% | 918.9% | -81.1% | -50.8% | -96.3% | -30.4% | 696.1% |
Frequently asked questions
What is Establishment Labs’s annual revenue?
$211M in fiscal 2025 and $264M over the twelve months to September 30, 2026.
How much profit does Establishment Labs make?
Net income was -$51M in fiscal 2025 (net margin -24.2%).
Is Establishment Labs’s revenue growing?
Yes: revenue rose 27.1% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.